WebDec 3, 2024 · CryoLife recently announced that it has received CE mark for the E-nside thoracoabdominal aortic aneurysm (TAAA) multibranch stent graft system for the endovascular treatment of TAAAs. Approximately 20,000 patients with thoracoabdominal disease are treated annually worldwide, which places the overall market at approximately … WebJan 18, 2024 · CryoLife, Inc.; Artivion, Inc. Jan 18, 2024, 08:10 ET ATLANTA, Jan. 18, 2024 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY ), a leading cardiac and vascular …
Products - CryoLife, Inc.
WebAug 27, 2024 · The aortic stent graft market is expected to reach over $3.7 billion by 2024, growing at an impressive CAGR of around 6% during 2024-2024. The commercialization of innovative grafts such as ... WebSep 2, 2024 · CryoLife Acquires Ascyrus Medical LLC, Developer of AMDS Hybrid Prosthesis. Ascyrus is a Florida-based, privately-held developer of the Ascyrus Medical Dissection Stent (AMDS™), the world’s first aortic … glf condition
CryoLife, Providing State of the Art Biomedical Services
WebFeb 4, 2016 · ATLANTA, Feb. 4, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY ), a leading medical device and tissue processing company focused on cardiac surgery, … WebMar 27, 2014 · Provides access for dialysis patients; complementary to HeRO® Graft. ATLANTA. -- CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has acquired the exclusive worldwide distribution rights for the ProCol Vascular Bioprosthesis ("ProCol") from … WebThe company preserves small diameter human saphenous vein conduits (3mm to 6mm) for use in peripheral vascular reconstructions and coronary bypass surgery. Failure to … glf construction asheville nc